William Garth Rapeport
11Patents
8h-index
12Co-inventors
61Inventor score
Filing activity: Oct 2, 2009 → Jan 6, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8299073B2 | P38 MAP kinase inhibitors | Chemistry; Metallurgy | 46 | Active |
| US8299074B2 | P38 MAP kinase inhibitors | Chemistry; Metallurgy | 44 | Active |
| US8293748B2 | p38 MAP kinase inhibitors | Chemistry; Metallurgy | 44 | Active |
| US8293771B2 | p38 MAP kinase inhibitors | Human Necessities | 44 | Active |
| US8642773B2 | P38MAP kinase inhibitor | Human Necessities | 42 | Active |
| US8618140B2 | P38 MAP kinase inhibitors | Chemistry; Metallurgy | 39 | Active |
| US8975285B2 | P38 MAP kinase inhibitors | Chemistry; Metallurgy | 26 | Active |
| US9079893B2 | Ureido-pyrazole derivatives for use in the treatment of respiratory syncitial virus (RSV) infection | Chemistry; Metallurgy | 21 | Active |
| US9260410B2 | P38 MAP kinase inhibitors | Human Necessities | 7 | Active |
| US9242960B2 | P38MAP kinase inhibitors | Human Necessities | 6 | Active |
| US10144721B2 | P38 MAP kinase inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.